{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:42:40Z","timestamp":1793900560611,"version":"4.8.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"FWO Vlaanderen","award":["1236321N"],"award-info":[{"award-number":["1236321N"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00467-023-06168-6","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T02:01:42Z","timestamp":1696039302000},"page":"1201-1212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6820-8321","authenticated-orcid":false,"given":"An","family":"Samaey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Francisco","family":"V\u00e1zquez-Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Caenepeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Vermeire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Raes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebl","family":"Knops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,30]]},"reference":[{"key":"6168_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s40121-016-0124-z","volume":"5","author":"A Cozar-Llisto","year":"2016","unstructured":"Cozar-Llisto A, Ramos-Martinez A, Cobo J (2016) Clostridium difficile infection in special high-risk populations. Infect Dis Ther 5:253\u2013269","journal-title":"Infect Dis Ther"},{"key":"6168_CR2","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMra1403772","volume":"372","author":"DA Leffler","year":"2015","unstructured":"Leffler DA, Lamont TJ (2015) Clostridium difficile infection. N Engl J Med 372:1539\u20131348","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"6168_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/ajt.12097","volume":"13","author":"ER Dubberke","year":"2013","unstructured":"Dubberke ER, Burdette SD (2013) Clostridium difficile infections in solid organ transplantation. Am J Transplant 13(Suppl 4):42\u201349","journal-title":"Am J Transplant"},{"key":"6168_CR4","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/tid.12584","volume":"18","author":"J Ciricillo","year":"2016","unstructured":"Ciricillo J, Haslam D, Blum S, Kim MO, Liu C, Paulsen G, Courter J, Danziger-Isakov L (2016) Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review. Transpl Infect Dis 18:706\u2013713","journal-title":"Transpl Infect Dis"},{"key":"6168_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/cid\/ciy149","volume":"66","author":"LC McDonald","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH (2018) Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66:987\u2013994","journal-title":"Clin Infect Dis"},{"key":"6168_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/jpids\/pix037","volume":"7","author":"MA O'Gorman","year":"2018","unstructured":"O\u2019Gorman MA, Michaels MG, Kaplan SL, Otley A, Kociolek LK, Hoffenberg EJ, Kim KS, Nachman S, Pfefferkorn MD, Sentongo T, Sullivan JE, Sears P (2018) Safety and pharmacokinetic study of fidaxomicin in children with clostridium difficile-associated diarrhea: a phase 2a multicenter clinical trial. J Pediatric Infect Dis Soc 7:210\u2013218","journal-title":"J Pediatric Infect Dis Soc"},{"key":"6168_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/apt.13144","volume":"41","author":"G Cammarota","year":"2015","unstructured":"Cammarota G, Masucci L, Ianiro G, Bibb\u00f2 S, Dinoi G, Costamagna G, Sanguinetti M, Gasbarrini A (2015) Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 41:835\u2013843","journal-title":"Aliment Pharmacol Ther"},{"key":"6168_CR8","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1053\/j.gastro.2018.12.019","volume":"156","author":"CL Hvas","year":"2019","unstructured":"Hvas CL, Dahl J\u00f8rgensen SM, J\u00f8rgensen SP, Storgaard M, Lemming L, Hansen MM, Erikstrup C, Dahlerup JF (2019) Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent clostridium difficile infection. Gastroenterology 156:1324\u20131332","journal-title":"Gastroenterology"},{"key":"6168_CR9","doi-asserted-by":"publisher","first-page":"1394379","DOI":"10.1155\/2018\/1394379","volume":"2018","author":"O Shogbesan","year":"2018","unstructured":"Shogbesan O, Poudel DR, Victor S, Jehangir A, Fadahunsi O, Shogbesan G, Donato A (2018) A systematic review of the efficacy and safety of fecal microbiota transplant for Clostridium difficile infection in immunocompromised patients. Can J Gastroenterol Hepatol 2018:1394379","journal-title":"Can J Gastroenterol Hepatol"},{"key":"6168_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/ajt.15058","volume":"19","author":"YW Cheng","year":"2019","unstructured":"Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman-Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Misch EA, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer M (2019) Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: a multicenter experience. Am J Transplant 19:501\u2013511","journal-title":"Am J Transplant"},{"key":"6168_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/ajt.12577","volume":"14","author":"RJ Friedman-Moraco","year":"2014","unstructured":"Friedman-Moraco RJ, Mehta AK, Lyon GM, Kraft CS (2014) Fecal microbiota transplantation for refractory Clostridium difficile colitis in solid organ transplant recipients. Am J Transplant 14:477\u2013480","journal-title":"Am J Transplant"},{"key":"6168_CR12","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1007\/s10620-021-07347-x","volume":"67","author":"K Suchman","year":"2022","unstructured":"Suchman K, Luo Y, Grinspan A (2022) Fecal microbiota transplant for Clostridioides Difficile infection is safe and efficacious in an immunocompromised cohort. Dig Dis Sci 67:4866\u20134873","journal-title":"Dig Dis Sci"},{"key":"6168_CR13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/ajg.2014.133","volume":"109","author":"CR Kelly","year":"2014","unstructured":"Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, Aroniadis O, Barto A, Borody T, Giovanelli A, Gordon S, Gluck M, Hohmann EL, Kao D, Kao JY, McQuillen DP, Mellow M, Rank KM, Rao K, Ray A, Schwartz MA, Singh N, Stollman N, Suskind DL, Vindigni SM, Youngster I, Brandt L (2014) Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 109:1065\u20131071","journal-title":"Am J Gastroenterol"},{"key":"6168_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13052-019-0708-9","volume":"45","author":"S Zhong","year":"2019","unstructured":"Zhong S, Zeng J, Deng Z, Jiang L, Zhang B, Yang K, Wang W, Zhang T (2019) Fecal microbiota transplantation for refractory diarrhea in immunocompromised diseases: a pediatric case report. Ital J Pediatr 45:116","journal-title":"Ital J Pediatr"},{"key":"6168_CR15","doi-asserted-by":"publisher","first-page":"e13598","DOI":"10.1111\/petr.13598","volume":"24","author":"JA Spinner","year":"2020","unstructured":"Spinner JA, Bocchini CE, Luna RA, Thapa S, Balderas MA, Denfield SW, Dreyer WJ, Nagy-Szakal D, Ihekweazu FD, Versalovic J, Savidge T, Kellermayer R (2020) Fecal microbiota transplantation in a toddler after heart transplant was a safe and effective treatment for recurrent Clostridiodes difficile infection: a case report. Pediatr Transplant 24:e13598","journal-title":"Pediatr Transplant"},{"key":"6168_CR16","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1097\/MPH.0000000000002023","volume":"43","author":"A Sabus","year":"2021","unstructured":"Sabus A, Merrow M, Heiden A, Boster J, Koo J, Franklin ARK (2021) Fecal Microbiota transplantation for treatment of severe Clostridioides difficile Colitis in a pediatric patient with non-Hodgkin lymphoma. J Pediatr Hematol Oncol 43:e897\u2013e899","journal-title":"J Pediatr Hematol Oncol"},{"key":"6168_CR17","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","volume":"375","author":"SV Lynch","year":"2016","unstructured":"Lynch SV, Pedersen O (2016) The human intestinal microbiome in health and disease. N Engl J Med 375:2369\u20132379","journal-title":"N Engl J Med"},{"key":"6168_CR18","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00467-016-3527-x","volume":"32","author":"P Evenepoel","year":"2017","unstructured":"Evenepoel P, Poesen R, Meijers B (2017) The gut-kidney axis. Pediatr Nephrol 32:2005\u20132014","journal-title":"Pediatr Nephrol"},{"key":"6168_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","volume":"83","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL (2013) Chronic kidney disease alters intestinal microbial flora. Kidney Int 83:308\u2013315","journal-title":"Kidney Int"},{"key":"6168_CR20","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1681\/ASN.2022030378","volume":"33","author":"J Holle","year":"2022","unstructured":"Holle J, Bartolomaeus H, L\u00f6ber U, Behrens F, Bartolomaeus TUP, Anandakumar H, Wimmer MI, Vu DL, Kuhring M, Br\u00fcning U, Maifeld A, Geisberger S, Kempa S, Schumacher F, Kleuser B, Bufler P, Querfeld U, Kitschke S, Engler D, Kuhrt LD, Drechsel O, Eckardt KU, Forslund SK, Th\u00fcrmer A, McParland V, Kirwan JA, Wilck N, M\u00fcller D (2022) Inflammation in children with CKD linked to gut dysbiosis and metabolite imbalance. J Am Soc Nephrol 33:2259\u20132275","journal-title":"J Am Soc Nephrol"},{"key":"6168_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nefro.2016.05.008","volume":"37","author":"S Cigarran Guldris","year":"2017","unstructured":"Cigarran Guldris S, Gonzalez Parra E, Cases Amenos A (2017) Gut microbiota in chronic kidney disease. Nefrologia 37:9\u201319","journal-title":"Nefrologia"},{"key":"6168_CR22","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.kint.2017.02.011","volume":"92","author":"E Mishima","year":"2017","unstructured":"Mishima E, Fukuda S, Mukawa C, Yuri A, Kanemitsu Y, Matsumoto Y, Akiyama Y, Fukuda NN, Tsukamoto H, Asaji K, Shima H, Kikuchi K, Suzuki C, Suzuki T, Tomioka Y, Soga T, Ito S, Abe T (2017) Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Kidney Int 92:634\u2013645","journal-title":"Kidney Int"},{"key":"6168_CR23","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/advances\/nmz028","volume":"10","author":"S Chung","year":"2019","unstructured":"Chung S, Barnes JL, Astroth KS (2019) Gastrointestinal microbiota in patients with chronic kidney disease: a systematic review. Adv Nutr 10:888\u2013901","journal-title":"Adv Nutr"},{"key":"6168_CR24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1126\/science.aad3503","volume":"352","author":"G Falony","year":"2016","unstructured":"Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, Kurilshikov A, Bonder MJ, Valles-Colomer M, Vandeputte D, Tito RY, Chaffron S, Rymenans L, Verspecht C, De Sutter L, Lima-Mendez G, D\u2019hoe K, Jonckheere K, Homola D, Garcia R, Tigchelaar EF, Eeckhaudt L, Fu J, Henckaerts L, Zhernakova A, Wijmenga C, Raes J (2016) Population-level analysis of gut microbiome variation. Science 352:560\u2013564","journal-title":"Science"},{"key":"6168_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP (2016) DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 13:581\u2013583","journal-title":"Nat Methods"},{"key":"6168_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature24460","volume":"551","author":"D Vandeputte","year":"2017","unstructured":"Vandeputte D, Kathagen G, D\u2019hoe K, Vieira-Silva S, Valles-Colomer M, Sabino J, Wang J, Tito RY, De Commer L, Darzi Y, Vermeire S, Falony G, Raes J (2017) Quantitative microbiome profiling links gut community variation to microbial load. Nature 551:507\u2013511","journal-title":"Nature"},{"key":"6168_CR27","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.1016\/j.watres.2013.07.051","volume":"47","author":"EI Prest","year":"2013","unstructured":"Prest EI, Hammes F, K\u00f6tzsch S, van Loosdrecht MC, Vrouwenvelder JS (2013) Monitoring microbiological changes in drinking water systems using a fast and reproducible flow cytometric method. Water Res 47:7131\u20137142","journal-title":"Water Res"},{"key":"6168_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.aca.2016.06.057","volume":"936","author":"H de Loor","year":"2016","unstructured":"de Loor H, Poesen R, De Leger W, Dehaen W, Augustijns P, Evenepoel P, Meijers B (2016) A liquid chromatography-tandem mass spectrometry method to measure a selected panel of uremic retention solutes derived from endogenous and colonic microbial metabolism. Anal Chim Acta 936:149\u2013156","journal-title":"Anal Chim Acta"},{"key":"6168_CR29","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/ajg.2015.149","volume":"110","author":"KL Kolho","year":"2015","unstructured":"Kolho KL, Korpela K, Jaakkola T, Pichai MV, Zoetendal EG, Salonen A, de Vos WM (2015) Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation. Am J Gastroenterol 110:921\u2013930","journal-title":"Am J Gastroenterol"},{"key":"6168_CR30","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41564-019-0483-9","volume":"4","author":"S Vieira-Silva","year":"2019","unstructured":"Vieira-Silva S, Sabino J, Valles-Colomer M, Falony G, Kathagen G, Caenepeel C, Cleynen I, van der Merwe S, Vermeire S, Raes J (2019) Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC\/IBD diagnoses. Nat Microbiol 4:1826\u20131831","journal-title":"Nat Microbiol"},{"key":"6168_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/jcag\/gwaa009","volume":"4","author":"BD Kyle","year":"2020","unstructured":"Kyle BD, Agbor TA, Sharif S, Chauhan U, Marshall J, Halder SLS, Ip S, Khan WI (2020) Fecal calprotectin, CRP and leucocytes in IBD patients: comparison of biomarkers with biopsy results. J Can Assoc Gastroenterol 4:84\u201390","journal-title":"J Can Assoc Gastroenterol"},{"key":"6168_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.amjms.2018.08.005","volume":"356","author":"FD Ihekweazu","year":"2018","unstructured":"Ihekweazu FD, Versalovic J (2018) Development of the pediatric gut microbiome: impact on health and disease. Am J Med Sci 356:413\u2013423","journal-title":"Am J Med Sci"},{"key":"6168_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fcimb.2019.00206","volume":"9","author":"F Li","year":"2019","unstructured":"Li F, Wang M, Wang J, Li R, Zhang Y (2019) Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease. Front Cell Infect Microbiol 9:206","journal-title":"Front Cell Infect Microbiol"},{"key":"6168_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/00325481.2020.1744335","volume":"132","author":"X Hu","year":"2020","unstructured":"Hu X, Ouyang S, Xie Y, Gong Z, Du J (2020) Characterizing the gut microbiota in patients with chronic kidney disease. Postgrad Med 132:495\u2013505","journal-title":"Postgrad Med"},{"key":"6168_CR35","doi-asserted-by":"publisher","first-page":"708472","DOI":"10.3389\/fimmu.2021.708472","volume":"12","author":"Y Yao","year":"2021","unstructured":"Yao Y, Cai X, Ye Y, Wang F, Chen F, Zheng C (2021) The role of microbiota in infant health: from early life to adulthood. Front Immunol 12:708472","journal-title":"Front Immunol"},{"key":"6168_CR36","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s10482-016-0737-y","volume":"109","author":"S Jiang","year":"2016","unstructured":"Jiang S, Xie S, Lv D, Zhang Y, Deng J, Zeng L, Chen Y (2016) A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression. Antonie Van Leeuwenhoek 109:1389\u20131396","journal-title":"Antonie Van Leeuwenhoek"},{"key":"6168_CR37","doi-asserted-by":"crossref","unstructured":"Campos-Perez W, Martinez-Lopez E (2021) Effects of short chain fatty acids on metabolic and inflammatory processes in human health. Biochim Biophys Acta Mol Cell Biol Lipids 1866:158900","DOI":"10.1016\/j.bbalip.2021.158900"},{"key":"6168_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4161\/gmic.23571","volume":"4","author":"MJ Hamilton","year":"2013","unstructured":"Hamilton MJ, Weingarden AR, Unno T, Khoruts A, Sadowsky MJ (2013) High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 4:125\u2013135","journal-title":"Gut Microbes"},{"key":"6168_CR39","doi-asserted-by":"crossref","unstructured":"Barba C, Soulage CO, Caggiano G, Glorieux G, Fouque D, Koppe L (2020) Effects of fecal microbiota transplantation on composition in mice with CKD. Toxins 12:741","DOI":"10.3390\/toxins12120741"},{"key":"6168_CR40","doi-asserted-by":"publisher","first-page":"e1007191","DOI":"10.1371\/journal.ppat.1007191","volume":"14","author":"IJ Passmore","year":"2018","unstructured":"Passmore IJ, Letertre MPM, Preston MD, Bianconi I, Harrison MA, Nasher F, Kaur H, Hong HA, Baines SD, Cutting SM, Swann JR, Wren BW, Dawson LF (2018) Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria. PLoS Pathog 14:e1007191","journal-title":"Plos Pathog"},{"key":"6168_CR41","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1053\/j.jrn.2017.02.010","volume":"27","author":"WL Lau","year":"2017","unstructured":"Lau WL, Vaziri ND (2017) The leaky gut and altered microbiome in chronic kidney disease. J Ren Nutr 27:458\u2013461","journal-title":"J Ren Nutr"},{"key":"6168_CR42","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.kint.2020.01.028","volume":"97","author":"T Gryp","year":"2020","unstructured":"Gryp T, De Paepe K, Vanholder R, Kerckhof FM, Van Biesen W, Van de Wiele T, Verbeke F, Speeckaert M, Joossens M, Couttenye MM, Vaneechoutte M, Glorieux G (2020) Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. Kidney Int 97:1230\u20131242","journal-title":"Kidney Int"},{"key":"6168_CR43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/toxins11040235","volume":"11","author":"E Snauwaert","year":"2019","unstructured":"Snauwaert E, Holvoet E, Van Biesen W, Raes A, Glorieux G, Vande Walle J, Roels S, Vanholder R, Askiti V, Azukaitis K, Bayazit A, Canpolat N, Fischbach M, Godefroid N, Krid S, Litwin M, Obrycki L, Paglialonga F, Ranchin B, Samaille C, Schaefer F, Schmitt CP, Spasojevic B, Stefanidis CJ, Van Dyck M, Van Hoeck K, Collard L, Eloot S, Shroff R (2019) Uremic toxin concentrations are related to residual kidney function in the pediatric hemodialysis population. Toxins 11:235","journal-title":"Toxins"},{"key":"6168_CR44","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/ndt\/gfx224","volume":"33","author":"E Snauwaert","year":"2018","unstructured":"Snauwaert E, Van Biesen W, Raes A, Glorieux G, Van Bogaert V, Van Hoeck K, Coppens M, Roels S, Vande Walle J, Eloot S (2018) Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population. Nephrol Dial Transplant 33:978\u2013986","journal-title":"Nephrol Dial Transplant"},{"key":"6168_CR45","doi-asserted-by":"crossref","unstructured":"Eloot S, Van Biesen W, Roels S, Delrue W, Schepers E, Dhondt A, Vanholder R, Glorieux G (2017) Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients. PLoS One 12:e0186010","DOI":"10.1371\/journal.pone.0186010"},{"key":"6168_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.plipres.2017.10.002","volume":"68","author":"L Xu","year":"2017","unstructured":"Xu L, Sinclair AJ, Faiza M, Li D, Han X, Yin H, Wang Y (2017) Furan fatty acids-beneficial or harmful to health? Prog Lipid Res 68:119\u2013137","journal-title":"Prog Lipid Res"},{"key":"6168_CR47","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/1462-2920.13318","volume":"18","author":"K Greenhalgh","year":"2016","unstructured":"Greenhalgh K, Meyer KM, Aagaard KM, Wilmes P (2016) The human gut microbiome in health: establishment and resilience of microbiota over a lifetime. Environ Microbiol 18:2103\u20132116","journal-title":"Environ Microbiol"},{"key":"6168_CR48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","volume":"66","author":"G Cammarota","year":"2017","unstructured":"Cammarota G, Ianiro G, Tilg H, Rajili\u0107-Stojanovi\u0107 M, Kump P, Satokari R, Sokol H, Arkkila P, Pintus C, Hart A, Segal J, Aloi M, Masucci L, Molinaro A, Scaldaferri F, Gasbarrini A, Lopez-Sanroman A, Link A, de Groot P, de Vos WM, H\u00f6genauer C, Malfertheiner P, Mattila E, Milosavljevi\u0107 T, Nieuwdorp M, Sanguinetti M, Simren M, Gasbarrini A (2017) European consensus conference on faecal microbiota transplantation in clinical practice. Gut 66:569\u2013580","journal-title":"Gut"},{"key":"6168_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40168-017-0269-3","volume":"5","author":"S Khanna","year":"2017","unstructured":"Khanna S, Vazquez-Baeza Y, Gonz\u00e1lez A, Weiss S, Schmidt B, Mu\u00f1iz-Pedrogo DA, Rainey JF, Kammer P, Nelson H, Sadowsky M, Khoruts A, Farrugia SL, Knight R, Pardi DS, Kashyap PC (2017) Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease. Microbiome 5:55","journal-title":"Microbiome"},{"key":"6168_CR50","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/apt.13326","volume":"42","author":"SK Hourigan","year":"2015","unstructured":"Hourigan SK, Chen LA, Grigoryan Z, Laroche G, Weidner M, Sears CL, Oliva-Hemker M (2015) Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease. Aliment Pharmacol Ther 42:741\u2013752","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06168-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-06168-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06168-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T16:09:12Z","timestamp":1709050152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-06168-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,30]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["6168"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-06168-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,30]]},"assertion":[{"value":"2 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The approval was granted by the Ethics Committee of University Hospitals Leuven.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}